Sorafenib induces autophagy and suppresses activation of human macrophage

International Immunopharmacology

Volumn 15, Issue 2, 2013, Pages 333-339

  Lin, Jiunn Chang ^a,b,c   Liu, Chien Liang ^b,c   Lee, Jie Jen ^b,d   Liu, Tsan Pai ^b,c   Ko, Wen Chin ^b   Huang, Yu Chuen ^e   Wu, Chih Hsiung ^f   Chen, Yu Jen ^b,d,g  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g CHINESE CULTURE UNIVERSITY   (Taiwan)

Author keywords

Autophagy; Macrophage; Sorafenib

Indexed keywords

ACRIDINE ORANGE; B7 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; MEMBRANE ANTIGEN; MICROTUBULE ASSOCIATED LIGHT CHAIN PROTEIN 3B 1; MICROTUBULE ASSOCIATED PROTEIN; REACTIVE OXYGEN METABOLITE; SORAFENIB; TRANSFORMING GROWTH FACTOR BETA; TRYPAN BLUE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL VIABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MICROSCOPY; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANTIGENS, CD14; ANTIGENS, CD80; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DOWN-REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSION; MACROPHAGE ACTIVATION; MACROPHAGES; MOLECULAR TARGETED THERAPY; NIACINAMIDE; PHENYLUREA COMPOUNDS; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES;

EID: 84873047792     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.01.006     Document Type: Article

References (17)

1. S. Gordon Innate immune functions of macrophages in different tissue environments J Innate Immun 4 2012 409 410
2. S.M. Wilhelm, C. Carter, L. Tang, D. Wilkie, A. McNabola, and H. Rong BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis Cancer Res 64 2004 7099 7109
3. B. Escudier, T. Eisen, W.M. Stadler, C. Szczylik, S. Oudard, and M. Siebels Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 2007 125 134
4. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
5. C.H. Hsieh, K.S. Jeng, C.C. Lin, C.K. Chen, C.Y. Liu, and C.P. Lin Combination of sorafenib and intensity modulated radiotherapy for unresectable hepatocellular carcinoma Clin Drug Investig 29 2009 65 71
6. M.S. Brose, C.M. Nutting, S.I. Sherman, Y.K. Shong, J.W. Smit, and G. Reike Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer BMC Cancer 11 2011 349
7. M.M. Hipp, N. Hilf, S. Walter, D. Werth, K.M. Brauer, and M.P. Radsak Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses Blood 111 2008 5610 5620
8. J.P. Edwards, and L.A. Emens The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE(2) in murine macrophages Int Immunopharmacol 10 2010 1220 1228
9. D.J. Klionsky, F.C. Abdalla, H. Abeliovich, R.T. Abraham, A. Acevedo-Arozena, and K. Adeli Guidelines for the use and interpretation of assays for monitoring autophagy Autophagy 8 2012 445 544
10. Y.J. Chen, W.P. Huang, Y.C. Yang, C.P. Lin, S.H. Chen, and M.L. Hsu Platonin induces autophagy-associated cell death in human leukemia cells Autophagy 5 2009 173 183
11. C.C. Mihalache, and H.U. Simon Autophagy regulation in macrophages and neutrophils Exp Cell Res 318 2012 1187 1192
12. L. English, M. Chemali, J. Duron, C. Rondeau, A. Laplante, and D. Gingras Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection Nat Immunol 10 2009 480 487
13. M.G. Gutierrez, S.S. Master, S.B. Singh, G.A. Taylor, M.I. Colombo, and V. Deretic Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages Cell 119 2004 753 766
14. Y. Zhao, D. Wilson, S. Matthews, and G.S. Yap Rapid elimination of Toxoplasma gondii by gamma interferon-primed mouse macrophages is independent of CD40 signaling Infect Immun 75 2007 4799 4803
15. E. Prentice, W.G. Jerome, T. Yoshimori, N. Mizushima, and M.R. Denison Coronavirus replication complex formation utilizes components of cellular autophagy J Biol Chem 279 2004 10136 10141
16. G. Liu, and H. Yang Modulation of macrophage activation and programming in immunity J Cell Physiol 228 2013 502 512
17. S. Gordon, and F.O. Martinez Alternative activation of macrophages: mechanism and functions Immunity 32 2010 593 604